newsfilter
← Latest News
GlobeNewswire·

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive's proprietary TCR-antigen datasets for research and development in